| Title | Author | Article Type |
|---|---|---|
| A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model | Y. Wu, Z. Qu, R. Xiong et al | Original Article |
| Viral determinants that drive Enterovirus-A71 fitness and virulence | P. Y. Ang, C. W. H. Chong & S. Alonso | Original Article |
| The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China | H. Jiang, Z. Zhang, Q. Rao et al | Original Article |
| Long-term neurodevelopment outcomes of hand, foot and mouth disease inpatients infected with EV-A71 or CV-A16, a retrospective cohort study | L. Liang, Y. Cheng, Y. Li et al | Original Article |
| Title | Author | Article Type |
|---|---|---|
| Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence | L. Sun, A. Tijsma, C. Mirabelli et al | Original Article |
| Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells | S. L. Chen, Y. G. Liu,Y. T. Zhou | Original Article |
| Title | Author | Article Type |
|---|---|---|
| Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade | P. Noisumdaeng, K. Sangsiriwut, J. Prasertsopon et al | Original Article |
| Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route | J. Zhu, N. Chen, S. Zhou et al | Original Article |
| Enterovirus 71 infection of human airway organoids reveals VP1-145 as a viral infectivity determinant | S. M. G. van der Sanden, N. Sachs, S. M. Koekkoek et al | Original Article |
| Title | Author | Article Type |
|---|---|---|
| Enterovirus 71 induces dsRNA/PKR-dependent cytoplasmic redistribution of GRP78/BiP to promote viral replication | J. R. Jheng, S. C. Wang, C. R. Jheng & J. T. Horng | Original Article |
| Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia | V. Duong, C. Mey, M. Eloit et al | Original Article |
| Title | Author | Article Type |
|---|---|---|
| EV71 vaccines: a milestone in the history of global vaccine development | S. Lu | Commentary |
| Title | Author | Article Type |
|---|---|---|
| A neonatal gnotobiotic pig model of human enterovirus 71 infection and associated immune responses | X. Yang, G. Li, K. Wen et al | Original Article |
| Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China | X. Wang, M. Xing,C. Zhang | Original Article |
| The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo | P. Ren, G. Zou, B. Bailly et al | Original Article |
| Receptors for enterovirus 71 | S. Yamayoshi, K. Fujii & S. Koike | Review |
| Title | Author | Article Type |
|---|---|---|
| Children of rural-to-urban migrant workers in China are at a higher risk of contracting severe hand, foot and mouth disease and EV71 infection: a hospital-based study | M. Zeng, D. Pu, X. Mo, et al | Original Article |
| EV71-infected CD14+ cells modulate the immune activity of T lymphocytes in rhesus monkeys | J. Wang, J. Pu, H. Huang, et al | Original Article |